Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Tech Coloproctol. 2024 Aug 13;28(1):102. doi: 10.1007/s10151-024-02980-w.
Diverting colostomy followed by neoadjuvant treatment is a treatment of choice for obstructive rectal cancer. Such patients may be treated via a robotic approach with several advantages over conventional laparoscopic surgery. Conversely, the existing stoma may interfere with the optimal trocar position and thus affect the quality of robotic surgery. Moreover, the console surgeon does not face the patient, which may endanger the stoma.
Patients with rectal cancer who underwent sphincter-preserving surgery were retrospectively investigated using a robotic platform after neoadjuvant treatment at our hospital. Based on pretreatment stoma creation, patients were divided into the NS (those without a stoma) and S groups (patients with a stoma). Baseline characteristics, types of neoadjuvant treatment, short-term surgical outcomes, postoperative anorectal manometric data, and survival were compared between the groups.
The NS and S groups comprised 65 and 9 patients, respectively. Conversion to laparotomy was required in three patients in the NS group. The S group required a longer console time than the NS group (median: 367 vs. 253 min, respectively, p = 0.038); however, no difference was observed in the total operative time (p = 0.15) and blood loss (p = 0.70). Postoperative complication rates, anorectal function, and oncological outcomes were similar between the groups.
Although console time was longer in patients with a stoma, robotic surgery could be performed safely like in those without a stoma after neoadjuvant treatment.
梗阻性直肠癌患者在接受新辅助治疗后行预防性结肠造口术是一种治疗选择。与传统腹腔镜手术相比,此类患者可通过机器人方法进行治疗,具有多项优势。然而,现有的造口可能会干扰最佳套管针位置,从而影响机器人手术的质量。此外,控制台医生不会面对患者,这可能会危及造口。
回顾性调查了在我院接受新辅助治疗后采用机器人平台行保肛手术的直肠癌患者。根据术前造口情况,将患者分为 NS(无造口)和 S 组(有造口)。比较两组患者的基线特征、新辅助治疗类型、短期手术结果、术后肛肠测压数据和生存情况。
NS 组和 S 组分别包括 65 例和 9 例患者。NS 组中有 3 例患者需要转为开腹手术。S 组的控制台时间长于 NS 组(中位数:367 比 253 分钟,p=0.038);然而,总手术时间(p=0.15)和出血量(p=0.70)无差异。两组患者的术后并发症发生率、肛肠功能和肿瘤学结果相似。
尽管有造口的患者控制台时间较长,但新辅助治疗后,机器人手术也可以像无造口患者一样安全进行。